Low cost HIV-1 quantitative RT-PCR assay in resource-limited settings: Improvement and implementation

Journal of Virological Methods

Volumn 185, Issue 1, 2012, Pages 118-123

  Fibriani, Azzania ^a,b   Farah, Nadya ^c   Kusumadewi, Inri ^c   Pas, Suzan D ^a   van Crevel, Reinout ^c,d   van der Ven, Andre ^d   Boucher, Charles A B ^a   Schutten, Martin ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^c PADJADJARAN UNIVERSITY   (Indonesia)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CRF01_AE; HIV 1 assay; Non subtype B; Viral load assay

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDONESIA; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT MONITORING; POL INTEGRASE GENE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; STANDARD; TREATMENT FAILURE; VIRUS GENE; VIRUS LOAD;

COSTS AND COST ANALYSIS; DRUG MONITORING; HIV INFECTIONS; HIV INTEGRASE; HIV-1; HUMANS; INDONESIA; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84864302657     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.06.015     Document Type: Article

References (25)

1. Alisjahbana B., Susanto H., Roesli R., Yusuf H., Hinduan Z., Mase J.C., Surahman E., van der Ven A. Prevention, control and treatment of HIV-AIDS among injecting drug use in Bandung, Indonesia. Acta Medica Indonesiana 2009, 41(Suppl. 1):65L 9.
2. Bertagnolio S., Parkin N.T., Jordan M., Brooks J., García-Lerma J.G. Dried blood spots for HIV-1 drug resistance and viral load testing: a review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Reviews 2010, 12:195-208.
3. Bonard D., Rouet F., Toni T.A., Minga A., Huet C., Ekouévi D.K., Dabis F., Salamon R., Rouzioux C. ANRS 1220 PRIMO-CI Study Group. Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa. Journal of Acquired Immune Deficiency Syndromes 2003, 34:267-273.
4. Braun J., Plantier J.C., Hellot M.F., Tuaillon E., Gueudin M., Damond F., Malmsten A., Corrigan G.E., Simon F. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 2003, 17:331-336.
5. Candotti D., Temple J., Owusu-Ofori S., Allain J.P. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. Journal of Virological Methods 2004, 118:39-47.
6. Charpentier C., Gody J.C., Tisserand P., Matta M., Fournier J., Mbitikon O., Bélec L. Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria. Archives of Virology 2011, [Epub ahead of print].
7. Clancy A., Crowley B., Niesters H., Herra C. The development of a qualitative real-time RT-PCR assay for the detection of hepatitis C virus. European Journal of Clinical Microbiology and Infectious Diseases 2008, 27:1177-1182.
8. Crump J.A., Scott L.E., Msuya E., Morrissey A.B., Kimaro E.E., Shao J.F., Stevens W.S. Evaluation of the Abbott m2000rt RealTime HIV-1 assay with manual sample preparation compared with the ROCHE COBAS AmpliPrep/AMPLICOR HIV-1 MONITOR v1.5 using specimens from East Africa. Journal of Virological Methods 2009, 162:218-222.
9. Drosten C., Panning M., Drexler J.F., Hänsel F., Pedroso C., Yeats J., de Souza Luna L.K., Samuel M., Liedigk B., Lippert U., Stürmer M., Doerr H.W., Brites C., Preiser W. Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clinical Chemistry 2006, 52:1258-1266.
10. Edelmann A., Kalus U., Oltmann A., Stein A., Unbehaun A., Drosten C., Krüger D.H., Hofmann J. Improvement of an ultrasensitive human immunodeficiency virus type 1 real-time reverse transcriptase-polymerase chain reaction targeting the long terminal repeat region. Transfusion 2010, 50:685-692.
11. Huang D., Zhuang Y., Zhai S., Song Y., Liu Q., Zhao S., Wang S., Li X., Kang W., Greengrass V., Plate M., Crowe S.M., Sun Y. HIV reverse transcriptase activity assay: a feasible surrogate for HIV viral load measurement in China. Diagnostic Microbiology and Infectious Disease 2010, 68:208-213.
12. Johannessen A. Dried blood spots in HIV monitoring: applications in resource-limited settings. Bioanalysis 2010, 2:1893-1908.
13. Malmsten A., Shao X.W., Aperia K., Corrigan G.E., Sandström E., Källander C.F., Leitner T., Gronowitz J.S. HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. Journal of Medical Virology 2003, 71:347-359.
14. Mwapasa V., Cachafeiro A., Makuta Y., Beckstead D.J., Pennell M.L., Chilima B., Mwagomba B., Fiscus S.A., Kwiek J.J. Using a simplified human immunodeficiency virus type 1 p24 antigen assay to diagnose pediatric HIV-infection in Malawi. Journal of Clinical Virology 2010, 49:299-302.
15. Paba P., Fabeni L., Ciccozzi M., Perno C.F., Ciotti M. Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study. Journal of Virological Methods 2011, 173:399-402.
16. Ribas S.G., Ondoa P., Schüpbach J., van der Groen G., Fransen K. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals. Journal of Virological Methods 2003, 113:29-34.
17. Riyarto S., Hidayat B., Johns B., Probandari A., Mahendradhata Y., Utarini A., Trisnantoro L., Flessenkaemper S. The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia. Health Policy and Planning 2010, 25:272-282.
18. Rouet F., Chaix M.L., Nerrienet E., Ngo-Giang-Huong N., Plantier J.C., Burgard M., Peeters M., Damond F., Ekouevi D.K., Msellati P., Ferradini L., Rukobo S., Maréchal V., Schvachsa N., Wakrim L., Rafalimanana C., Rakotoambinina B., Viard J.P., Seigneurin J.M., Rouzioux C. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA quantitation: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. Journal of Acquired Immune Deficiency Syndromes 2007, 45:380-388.
19. Rouet F., Ekouevi D.K., Chaix M.L., Burgard M., Inwoley A., Tony T.D., Danel C., Anglaret X., Leroy V., Msellati P., Dabis F., Rouzioux C. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting. Journal of Clinical Microbiology 2005, 43:2709-2717.
20. Sire J.M., Vray M., Merzouk M., Plantier J.C., Pavie J., Maylin S., Timsit J., Lascoux-Combe C., Molina J.M., Simon F., Delaugerre C. Comparative RNA quantitation of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. Journal of Acquired Immune Deficiency Syndromes 2011, 56:239-243.
21. Sizmann D., Glaubitz J., Simon C.O., Goedel S., Buergisser P., Drogan D., Hesse M., Kröh M., Simmler P., Dewald M., Gilsdorf M., Fuerst M., Ineichen R., Kirn A., Pasche P., Wang Z., Weisshaar S., Young K., Haberhausen G., Babiel R. Improved HIV-1 RNA quantitation by COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0 using a novel dual-target approach. Journal of Clinical Virology 2010, 49:41-46.
22. Stadhouders R., Pas S.D., Anber J., Voermans J., Mes T.H., Schutten M. The effect of primer-template mismatches on the detection and quantitation of nucleic acids using the 5' nuclease assay. Journal of Molecular Diagnostics 2010, 12:109-117.
23. Stewart P., Cachafeiro A., Napravnik S., Eron J.J., Frank I., van der Horst C., Bosch R.J., Bettendorf D., Bohlin P., Fiscus S.A. Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay. Journal of Clinical Virology 2010, 49:198-204.
24. UNAIDS, 2010. Global report: UNAIDS report on the global AIDS epidemic 2010. WHO Library Cataloguing-in-Publication Data. Geneva, Switzerland.
25. Vessière A., Rousset D., Kfutwah A., Leoz M., Depatureaux A., Simon F., Plantier J.C. Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun. Journal of Acquired Immune Deficiency Syndromes 2010, 53:107-110.